Letaplimab represents a novel therapeutic approach for managing complement-mediated diseases. This biologic targets complement component C1q, a critical component of the complement cascade, aiming to disrupt its first https://alyshaffoc711737.aboutyoublog.com/52729372/letaplimab-a-groundbreaking-therapeutic-strategy